SGLT2 Inhibitors as Early Therapy for HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction
Eur. J. Heart Fail 2021 Dec 10;[EPub Ahead of Print], D Tomasoni, GC Fonarow, M Adamo, SD Anker, J Butler, AJS Coats, G Filippatos, SJ Greene, TA McDonagh, P Ponikowski, G Rosano, P Seferovic, M Vaduganathan, AA Voors, M MetraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.